Related Experiment Video
Updated: Aug 14, 2026
Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
Published on: July 23, 2012
Alzheimer's genes in microglia: a risk worth investigating
Ari Sudwarts1,2, Gopal Thinakaran3,4
1Byrd Alzheimer's Center and Research Institute, University of South Florida, Tampa, FL, 33613, USA. asudwarts@usf.edu.
Abstract:
Despite expressing many key risk genes, the role of microglia in late-onset Alzheimer's disease pathophysiology is somewhat ambiguous, with various phenotypes reported to be either harmful or protective. Herein, we review some key findings from clinical and animal model investigations, discussing the role of microglial genetics in mediating perturbations from homeostasis. We note that impairment to protective phenotypes may include prolonged or insufficient microglial activation, resulting in dysregulated metabolomic (notably lipid-related) processes, compounded by age-related inflexibility in dynamic responses. Insufficiencies of mouse genetics and aggressive transgenic modelling imply severe limitations in applying current methodologies for aetiological investigations. Despite the shortcomings, widely used amyloidosis and tauopathy models of the disease have proven invaluable in dissecting microglial functional responses to AD pathophysiology. Some recent advances have brought modelling tools closer to human genetics, increasing the validity of both aetiological and translational endeavours.
Insights
Microglia
Area of Science:
- Neuroscience
- Immunology
- Genetics
Background:
- Microglia's role in late-onset Alzheimer's disease (AD) is complex, with conflicting evidence on their protective or detrimental effects.
- Genetic factors significantly influence microglial behavior and responses in AD.
- Age-related changes can impair microglial homeostatic functions.
Purpose of the Study:
- To review current clinical and animal model findings on microglial genetics in Alzheimer's disease.
- To discuss how microglial phenotypes and their genetic underpinnings contribute to AD pathophysiology.
- To evaluate the limitations and advances in modeling microglial responses in AD research.
Main Methods:
- Review of clinical and animal model investigations.
- Analysis of microglial genetic risk factors and their impact on homeostasis.
- Discussion of metabolomic and dynamic response alterations.
Main Results:
- Impaired protective microglial phenotypes can result from prolonged/insufficient activation, leading to metabolic dysregulation (e.g., lipid processes).
- Age-related inflexibility further compromises microglial responses.
- Current mouse models have limitations but have been crucial for understanding microglial functional responses to AD pathology.
Conclusions:
- Despite methodological challenges, understanding microglial genetics is vital for Alzheimer's disease research.
- Advances in modeling are improving the validity of etiological and translational studies.
- Targeting microglial genetic pathways may offer therapeutic avenues for AD.
